Whole Blood Aggregation Assay is used for Aspirin and Plavix therapy

Concerned about the risk of thrombosis or bleeding with your CAD patients? Chrono-log can provide you with the ability to perform quick platelet function screening. Monitor the effects of anti-platelet drugs such as… 1. Clopidogrel [Plavix] – determining pharmacodynamic or pharmacokinetic resistance 2. Aspirin – measuring extent of response to therapy  3. GPIIb/IIIa receptor blockage - including post-treatment platelet recovery…using a Whole Blood Impedance assay. In a study published in 2005, it was concluded that: "The WB impedance assay should be widely used in the clinical practice to identify subjects who are resistant to aspirin and clopidogrel."

Chrono-log Corporation has been a leading manufacturer of platelet function testing devices since the mid-1960’s, with systems operating worldwide in Clinical and Research Laboratories. Whole Blood/Optical Lumi-Aggregation Systems improve detection of abnormal platelet function by simultaneously measuring platelet aggregation and dense granule secretion in a physiologic whole blood environment or in the traditional plasma sample. Need to monitor anti-platelet therapy AND detect platelet defects? The NEW and highly versatile Model 700 combines the comprehensive diagnostic capability of Lumi-Aggregation with rapid and simple Whole Blood screening in one easy-to-use system.

Chrono-log also offers a complete line of Platelet Aggregometers and Reagents to diagnose specific platelet disorders. To obtain free reprint articles on how Chrono-log Whole Blood Aggregometers can provide you with the ability to perform quick platelet function screen to monitor the effectiveness of aspirin and other anti-platelet drugs, visit our ABSTRACT page.

 

 

   

   

                                                                                                         

                                                                                                                                

© 2006 Chrono-log Corporation